EDVA (Endovia Health Sciences) EBIT: $-13.75 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EDVA Endovia Health Sciences Inc EDVA
23 GF Score
Price $0.39
! 8 Warning Signs
View Full Analysis

What is Endovia Health Sciences EBIT?

Endovia Health Sciences EDVA +3.56% 23 EBIT is $-13.75 Mil as of Jun. 2026. GuruFocus rates EDVA with a GF Score™ of 23/100. The stock has 8 warning signs investors should review.

Endovia Health Sciences's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2026 was $-1.76 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2026 was $-13.75 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Endovia Health Sciences's annualized ROC % for the quarter that ended in Jun. 2026 was -98.23%. Endovia Health Sciences's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was -32,072.73%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Endovia Health Sciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was -159.60%.


Endovia Health Sciences  (AMEX:EDVA) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Endovia Health Sciences's annualized ROC % for the quarter that ended in Jun. 2026 is calculated as:

ROC % (Q: Jun. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2026 ) + Invested Capital (Q: Jun. 2026 ))/ count )
=-8.028 * ( 1 - 0% )/( (8.082 + 8.264)/ 2 )
=-8.028/8.173
=-98.23 %

where

Note: The Operating Income data used here is four times the quarterly (Jun. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Endovia Health Sciences's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2026  Q: Jun. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-7.056/( ( (0.044 + max(-10.371, 0)) + (0 + max(-9.853, 0)) )/ 2 )
=-7.056/( ( 0.044 + 0 )/ 2 )
=-7.056/0.022
=-32,072.73 %

where Working Capital is:

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.02 + 0.055 + 0.177) - (8.951 + 0 + 1.672)
=-10.371

Working Capital(Q: Jun. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.014 + 0.055 + 0.516) - (8.737 + 0 + 1.701)
=-9.853

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Endovia Health Sciences's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2026 )
=-13.751/8.616
=-159.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Endovia Health Sciences EBIT Related Terms


Endovia Health Sciences EBIT Historical Data

* Premium members only.

The historical data trend for Endovia Health Sciences's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Endovia Health Sciences EBIT Chart

Endovia Health Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -28.90 -21.39 -15.31 -10.23 -19.98

Endovia Health Sciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.06 -9.54 -1.21 -1.23 -1.76

EDVA vs YHC, IBG, BF.B: EBIT Comparison

For the Beverages - Wineries & Distilleries subindustry, Endovia Health Sciences's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Endovia Health Sciences EV-to-EBIT vs Beverages - Alcoholic Industry

For the Beverages - Alcoholic industry and Consumer Defensive sector, Endovia Health Sciences's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Endovia Health Sciences's EV-to-EBIT falls into.


EDVA
23GF Score
Endovia Health Sciences Inc EDVA
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Endovia Health Sciences EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-13.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-13.75 Mil mean?
Endovia Health Sciences (EDVA) has a EBIT of $-13.75 Mil as of Jun. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Endovia Health Sciences.
Is Endovia Health Sciences' EBIT too high?
Endovia Health Sciences' current EBIT is $-13.75 Mil. Overall, Endovia Health Sciences has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Endovia Health Sciences' EBIT compare to YHC and IBG?
Endovia Health Sciences' EBIT of $-13.75 Mil can be compared against companies in the Beverages - Alcoholic industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Beverages - Alcoholic company?
A good EBIT depends on the Beverages - Alcoholic industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Endovia Health Sciences. Endovia Health Sciences's current EBIT is $-13.75 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Endovia Health Sciences stock overvalued right now?
Endovia Health Sciences (EDVA) has a current EBIT of $-13.75 Mil. The current EBIT is $-13.75 Mil. Endovia Health Sciences' overall GF Score™ is 23/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Endovia Health Sciences (EDVA), the current EBIT is $-13.75 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Endovia Health Sciences Business Description

Address 1314 East Las Olas Boulevard, Suite 221, Fort Lauderdale, FL, USA, 33301
Splash Beverage Group Inc is a portfolio company managing multiple brands across several growth segments within the consumer beverage industry. The company's two reportable operating segments are: (1) the manufacture and distribution of non-alcoholic and alcoholic beverages, and (2) the retail sale of beverages and groceries online. The company generates the majority of its revenue from the E-Commerce.
23GF Score

Get the complete analysis for EDVA

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.39
Price